BIT's 7th Annual International Congress of Antibodies-2015
About ICA - 2015

The Annual International Congress of Antibodies (ICA), initiated from 2009, had been successfully organized in Beijing, Hangzhou and Dalian, attracted more than 2,500 participants from 60 countries. ICA series congresses contribute to offering professionals in the field of antibody a multidisciplinary informative cooperative platform, and it has been the most definite and grand Antibody event in Asia. The ICA-2015, with the theme of ”Innovations from Defending Surface to Penetrating the Membrane” will be held on April 25-28, 2015 in Nanjing, China.

Nobel Laureates-2015

Dr. Bruce A. Beutler,
Professor, UT Southwestern,
USA

 

Nobel Prize laureate in Physiology or Medicine, 2011

Dr. Tim Hunt,
Emeritus Group Leader, Clare Hall Laboratories,
UK

 

Nobel Prize laureate in Physiology or Medicine, 2001
Keynote Speakers
Dr. Andrew Wang, Chairman, Taiwan Antibody Association, Taiwan Dr. Liangzhi Xie, Founder & CEO, Sino Biological Inc., China
Dr. Steffen R Nock, VP & Global Head of Biologics, Teva, USA Dr. Chien-Hsing Ken Chang, Vice President, Research and Development, Immunomedics, Inc., USA
Dr. Michael Yu, Presidert, Innovent Biologics, Inc., China    
Program Layout
Sector 1: Main Conference
Part 1: Opening Ceremony and Keynote Forum Part 3: New Paradigm for International Collaboration on Antibody Development
Part 2: Global Antibody Economics and Market Trend Part 4: Antibody Safety, Quality Assurance, Policy and Regulatory Issues
Sector 2: Breaking Research of Antibodies
Track 1: Frontier of Antibody Research Track 3: Antibody Structure Prediction and Antibody Design
Track 2: Antibody Discovery and Technology Platforms  
Sector 3: Medical Applications of Antibodies, Antibody Engineering
Track 4: Antibody for Disease Diagnosis Track 8: Antibody-Mediated Drug Delivery System and Antibody Formulation
Track 5: Antibody-Drug Conjugates, Bispecific and Multispecific Antibodies Track 9: Antibody Engineering, Purification and Production
Track 6: Therapeutic Antibodies Track 10: Translational Medicine of Antibodies
Track 7: Antibody Biosimilars and Biobetters  
Sector 4: Non-medical Applications of Antibodies
Track 11: Antibodies in Food, Environmental and Agricultural Sciences Track 12: Antibodies in Food, Environmental and Agricultural Sciences
Sector 5: Parallel Scientific and Technological Conferences
BIT's 6th Annual World DNA & Genome Day 2015 BIT’s 4th Annual Conference and EXPO of AnalytiX 2015 (AnalytiX-2015)
BIT’s 6th Symposium of Enzyme &Biocatalysis (SEB-2015) BIT’s 7th Annual World Congress of Vaccines (WCV-2015)
BIT’s 5th World Congress of Molecular & Cell Biology (CMCB-2015) BIT’s 8th Annual World Protein and Peptide Conference (PepCon-2015)
BIT’s 8th World Congress of Industrial Biotechnology (IBIO-2015)  
Sector 6: Business and Career Development
Track 13: Antibody Business and Investment Track 14: Antibody Career Development
Sector 7: Posters and Exhibition
ICA-2015 will provide an ideal platform to showcase your new technologies and products in China. It is developed to maximize exposure of exhibitors, with coffee breaks and poster sessions for delegates taking place in the exhibition area.
  • Exposure Your New Products, Technology, Innovations and Latest Development to Visitors
  • Explore Business Opportunities in China and Beyond
  • Interaction with Visitors Face-to-Face, Exchanging Conversation and Sharing Information
  • Spotlight Your Technology and Its Commercial Application Promote Business
  • Take Advantage of the Targeted Audience at the Conference and Network in the Hall
  • Highlight your Impact and Influence
  • Increased Visibility and Name Recognition
  • Access to Competitive Intelligence
Sector 8: Social Events
Event 1: Culture Activities-Art Performance and Show
Event 2: Cocktail Social Networking
Event 3: City Tour As Requested
Event 4: Field Trip to Universities/Industries, and Networking Tour
Past Event Report

The 6th Annual International Congress of Antibodies 2014 (ICA-2014) has been held in Dalian International Conference Center from April 25-28 in Dalian, China. It was jointly held with the 5th Annual World DNA and Genome Day, the 7th Annual congress of Industrial Biotechnologh, the 7th Annual World Protein & Peptide Conference, the 6th Annual World congress of Vaccine, the 5th Symposium on Enzymes & Biocatalysis, the 4th Annual World congress of Molecular & Cell Biology, the 3rd Annual conference and EXPO of Analytix and the 5th Bio-Expo-2014, and has achieved great success, it is unprecedented grand.

This year’s conference has invited eleven Nobel masters and attracted more than 1500 participants from domestic and abroad. Many honored guests presented at the Nobel and keynote forum. In addition, there were 14 sessions following the Opening Ceremony covering 5 fields including Breaking Research on Antibody, Innovative Tech Platforms for Antibodies, Antibody Based Drug Discovery and Therapy-From Early to Late Stage, Antibodies in Medical Diagnosis, Antibody Engineering and Production.

After the conference many participants expressed their satisfaction with the content of the congress and had fine memories of Dalian. We believe that with the support and constructive suggestions from attendees, the next conference ICA-2015 will be even better.

Media

China Local Time
Days to Go!
News Release

The scientific program is released.
• Call for speakers, exhibitors and sponsors worldwide.
• Call for media partners and advertiser worldwide.
Register now to secure your attendance.

Call for papers

Hosting Organization

Information Research Center of International Talent, China State Administration of Foreign Experts Affairs, China

Operating Organization

China Council for the Promotion of Intemational Trade, Nanjing Sub-Council



BIT Congress Inc.

Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

Official Travel Agency

BIT World Travel Service, Inc.

 

SkyTeam

Renowned Speakers
Dr. Jijie Gu,
Senior Principal Research Scientist, Global Biologics, AbbVie, USA
Dr. Eva Kimby,
Professor, Karolinska University Hospital, Sweden
Dr. Rafael Mendoza,
Senior Director, Pfizer, Hong Kong
Dr. Mitchell Ho,
Head, NIH, USA
Dr. Chengbin Wu,
President of RD, Shanghai CP Guojian Pharmaceutical, China
Dr. Dimiter S Dimitrov,
Head, National Cancer Institute, USA
Dr. Roman Ivanov,
Vice-President, R&D CJSC Biocad, Russia
Dr. Dan Zhang,
Chairman and CEO, Fountain Medical Development Ltd., China
Dr. Kaia Agarwal,
President, Regulatory Compass, LLC., USA
Dr. Bo Yu,
Co-founder and CSO, Larix Bioscience LLC, USA
Dr. Mingjiu Chen,
President and CEO, biosynergics Inc., China
Dr. Erwan Corcuff,
CEO., Axenis, France
Ms. Lidia Retkowska-Mika,
Head, Office for Registration of Medicinal Products, Poland
Dr. Jian Li,
Principal Scientist, Pfizer Inc., USA
Dr. Patell Villoo Morawala,
Founder Chairperson, Avesthagen Limited, India
Dr. Ken H. Young,
Professor, The University of Texas MD Anderson Cancer Center, USA
Dr. Jun Wang,
CEO, GeneHarbor Biotechnologies Ltd., China
Dr. Seth D. Ginsberg,
President, Global Healthy Living Foundation, USA
Dr. Thomas Böldicke,
Professor, Helmholtz-Centre for Infection Research, Germany
Dr. Serge Muyldermans,
Professor, Vrije Universiteit Brussel, Belgium
Dr. Lars Dreesmann,
Executive Director, Boehringer Ingelheim Pharma GmbH&Co.KG, Germany
Dr. Martin Lemmerer,
Principal Scientist, Novartis Institutes for BioMedical Research, Inc., USA
Dr. Liselotte Brix,
COO, Immudex, Denmark
Dr. Eugene Zhukovsky,
CSO, Affimed Therapeutics AG, UK
Dr. George (Zhuozhi) Wang,
Group Head/Sr Staff Scientist, Bayer, USA
Dr. Marko Z. Radic,
Professor, University Tennessee Health Science Center, USA
Dr. Jian Ni,
CEO, The National Engineering Research Center of Antibody Medicine (CMAB), China
Dr. Dongfeng Tan,
Professor, the University of Texas M. D. Anderson Cancer Center, USA
Dr. Mayra Ramos Suzarte,
Head, Center of Molecular Immunology, Cuba
Dr. Shahla Masood,
Professor and Chair, University of Florida, USA
Dr. Joseph F. John,
Professor and Chief, Medical University of South Carolina, USA
Dr. William Haseltine,
Founder, Chairman of the Board and CEO, Human Genome Sciences, USA
Dr. Damian F.J. Purcell,
Professor, University of Melbourne, Australia
Dr. Mahendra N Mishra,
Chief, Command Hospital, India
Dr. Gabriel A. Rabinovich,
Director, Universidad de Buenos Aires, Argentina
Dr. Renfeng Guo,
Co-Founder, CSO, InflaRx Gmbh., Germany
Dr. Fiona Greer,
Director, SGS M-Scan, UK
Dr. David P. Humphreys,
Senior Group Leader, UCB-New Medicines, UK
Dr. Thomas O. Kohl,
Director, ImmunoGenes AG, USA
Dr. Abdul-Wajid,
Senior Director, XOMA, USA
Dr. Gary McLean,
Senior Lecturer, Cellular and Molecular Immunology Research Centre, London Metropolitan University , UK
Dr. Michael Schraeml,
Head, Roche Diagnostics GmbH, Germany
Dr. Qiang Yu,
Professor, Chinese Academy of Sciences, China
Dr. Terry Dyck,
President, CEO, IGY Immune Technologies Life Sciences Inc., Canada
Dr. Ralf Ostendorp,
Vice President, Protein Sciences, MorphoSys AG, Germany

Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.